Replies to post #627824 on NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

I'm uncertain if they'll PR the submittal, or wait for the acceptance. If they feel very confident in acceptance, it's a good PR move, but if the regulator requests a change that requires delay, then it becomes a negative as investors question if something is wrong. Most companies announce acceptance, rather than submissions, though if they do announce the submission they'll also note acceptance normally.

In our case, if it's a rolling submission in which nearly all the application has been accepted, the only question is about what's being newly submitted. Of course it's possible that the last part to be submitted is the one that they're most concerned about, perhaps the acceptance criteria the company believes should be applied, if it's up to them to make such a recommendation.

Gary

[HappyLibrarian]

NWBO left themselves wiggle room to not actually announce submission though if they were willing to announce the mere anticipation of submission it would be hard for them to logically say that actual submission is somehow less newsworthy than mere anticipation of the same.

I think NWBO has to know that if they fail to announce submission it’s going to hurt the credibility they just started restoring this month and if they didn’t care about that then why even announce anticipation of submission at all?

So for that reason I am as confident as someone who went through all this for years that they finally learned from their mistake in communication between September and October 2020. Even I don’t think they are going to repeat something similar close to the 3rd anniversary of those events and believe I am suspicious.